Hybrid and active containers are both used to transport temperature-sensitive pharmaceuticals globally, but they approach cold chain protection differently. Active containers use powered refrigeration systems and charging infrastructure to maintain temperature control, while hybrid containers (e.g., SkyCell) maintain validated temperature ranges autonomously without requiring external power during transit.
Active pharmaceutical containers use powered refrigeration systems to maintain temperature control during transport.
These systems typically include:
Examples include:
Active systems are widely used in pharmaceutical airfreight, particularly for:
Because they actively regulate temperature, they can provide highly controlled transport environments during normal operations.
A hybrid container in pharmaceutical logistics is a temperature-controlled shipping container that maintains pharmaceutical products within validated temperature ranges comparable to active systems, without requiring external power or batteries in transit.
Hybrid containers are designed to be handled like passive freight, reducing dependency on ground infrastructure and minimizing human intervention across the entire shipment journey.
Examples include:
Hybrid systems combine:
This approach is increasingly used for:
Historically, pharmaceutical cold chain discussions focused heavily on refrigeration technology itself.
Today, the larger challenge is often operational. Most temperature excursions occur during:
This means pharmaceutical companies increasingly evaluate:
alongside temperature control performance.
| Capability Area | Active Containers | Hybrid Containers |
| Temperature Control Method | Powered refrigeration system | Autonomous thermal protection system |
| Infrastructure Dependency | Requires charging and plug infrastructure | No external power required during transit |
| Runtime During Delays | Shorter runtime than hybrid which can result in dependency on charging availability and battery management | Long autonomous runtime without plug dependency |
| Airport Dwell Resilience | Vulnerable if runtime exceeded and charging access is delayed or unavailable | Designed to tolerate prolonged dwell autonomously |
| Customs Handling Exposure | May require additional handling during inspections | X-ray compatible designs can reduce manual inspection exposure |
| Operational Complexity | Higher infrastructure coordination requirements | No dependency on infrastructure and easy to handle |
| Sustainability Profile | Higher infrastructure and energy dependency | Lower infrastructure dependency and reduced reverse logistics emissions |
| Best Fit | Stable infrastructure-rich global corridors | Complex, disruption-prone international pharma lanes |
As biologics logistics becomes more operationally complex, resilience during disruption is becoming increasingly important in system evaluation.
Airports are one of the highest-risk environments in pharmaceutical logistics.
Shipments may experience:
According to IATA, over 50% of temperature excursions occur at airports.
This is where the operational differences between active and hybrid systems become most visible.
Systems that depend heavily on:
may become more vulnerable when operational disruption occurs.
By contrast, systems with long autonomous runtime can continue protecting shipments without immediate infrastructure intervention.
Runtime is one of the most important factors in cold chain resilience.
When delays exceed planned schedules, systems with insufficient autonomous protection become increasingly vulnerable.
For example:
Because these systems do not require plugs or external power during transit, they can tolerate:
with lower operational dependency.
Active solution runtimes vary between provider and container. Envirotainer, for example offers several products with a runtime range of between 48 hours and 170 hours. This provides up to a week of independent runtime. For longer shipments or in the case of delays, active solutions may not be able to maintain temperature control without intervention.
Customs inspections are a major operational exposure point in pharmaceutical airfreight.
Opening containers can:
Some hybrid systems are designed specifically to reduce this exposure.
For example:
These operational characteristics become increasingly important on:
Active solutions may container components that block the X-Ray machine from seeing clearly, requiring the container to be manually opened and inspected.
Modern pharmaceutical logistics increasingly depends on:
Container performance alone is no longer sufficient for many biologics supply chains.
Some systems now combine physical protection with:
to reduce excursion risk during operational disruption.
Both active and hybrid solutions incrporate some form of tracking however the level of intervention possible varies.
SkyCell combines hybrid temperature-controlled containers with operational visibility and intervention infrastructure designed specifically for pharmaceutical logistics.
SkyCell hybrid containers maintain validated temperature ranges without requiring external power during transit.
This reduces dependency on:
during operational disruption.
SkyCell’s visibility network spans:
The company tracks:
This helps identify:
across major pharmaceutical airfreight hubs.
Validaide provides:
The platform includes:
This helps pharmaceutical companies improve operational planning and intervention capability across global supply chains.
SkyCell reports an independently assessed:
across global operations.
This reflects a broader operational approach focused on:
rather than refrigeration performance alone.
Cold chain sustainability increasingly depends on infrastructure intensity.
Active systems may require:
throughout the shipment journey.
Hybrid systems can reduce:
SkyCell’s Net ZERO Reverse model further reduces emissions by eliminating unnecessary air freight returns for empty containers and using ocean freight repositioning instead.
This supports lower-emission pharmaceutical airfreight operations globally.
There is no single universal solution for every pharmaceutical shipment.
Active systems may perform strongly in:
Hybrid systems increasingly perform strongly on:
because they reduce dependency on external infrastructure during disruption.
As pharmaceutical supply chains become more complex, companies increasingly evaluate cold chain systems based on:
rather than cooling technology alone.
The strongest systems increasingly combine:
to reduce cold chain risk across global biologics logistics.
.png?width=1200&height=675&name=bookin%20portal%20graphic%20-%20corporate%20newsletter%20(1).png)